Substituted thiazolidinedione derivative, process for its...

Details Substituted thiazolidinedione derivative, process for its... Substituted thiazolidinedione derivative, process for its...

2008-05-06

2008-05-06

Morris, Patricia L. (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

07368574

ABSTRACT:
A hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt., characterized in that it:(i) comprises water in the range of from 0.3 to 0.6 molar equivalents; and(ii) provides an infra red spectrum containing peaks at 1757, 1331, 1290, 1211 and 767 cm−1; and/or(iii) provides a Raman spectrum containing peaks at 1758, 1610, 1394, 1316 and 1289 cm−1; and/or(iv) provides a solid state nuclear magnetic resonance spectrum containing chemical shifts substantially as set out in Table I herein; and/or(v) provides an X-ray powder diffraction (XRPD) pattern substantially as set out in FIG. IV herein; a process for the preparation of such a compound, a pharmaceutical composition containing such a compound and the use of such a compound or composition in medicine.

REFERENCES:
patent: 5002953 (1991-03-01), Hindley
patent: 5741803 (1998-04-01), Pool et al.
patent: 5910592 (1999-06-01), Pool et al.
patent: 6288095 (2001-09-01), Hindley
patent: 2002/0099081 (2002-07-01), Blackler et al.
patent: 2002/0137940 (2002-09-01), Blackler et al.
patent: 0 306 228 (1999-11-01), None
patent: WO 93/10254 (1993-03-01), None
patent: WO 94/05659 (1994-03-01), None
patent: WO 95/21603 (1995-08-01), None
patent: WO 02/26737 (2002-04-01), None
Cantello, et al., “The Synthesis of BRL 49653—A Novel and Potent Antihyperglycaemic Agent”.Bioorganic&Medicinal Chemistry Letters, 4(10): 1181-1184 (1994).
Haleblian, et al., “Pharmaceutical Applications of Polymorphism”.Journal of Pharmaceutical Sciences, 58(8): 911-929 (1969).
Brittain, et al. Polymorphism in Pharmaceutical Solids, NY: Marcel Dekker, Inc., 1999, pp. 125-181, 183-226, 228-330, and 331-361.
Chemical & Engineering News, Feb. 2003, pp. 32-35.
US Pharmacopia, 1995, pp. 1843-1844.
Concise Encyclopedia Chemistry, pp. 872-873 (1993).
U.S. Appl. No. 10/321,055, filed Dec. 17, 2002, Blackler et al.
U.S. Appl. No. 10/030,323, filed Apr. 19, 2000, Blackler et al.
U.S. Appl. No. 10/048,123, filed Apr. 19, 2000, Blackler et al.
U.S. Appl. No. 10/030,877, filed Apr. 19, 2000, Blackler et al.
Ulicky et al. Comprehensive Dictionary of Physical Chemistry, NY: Prentice Hall, 1992, p. 21.
Vippagunta et al. “Crystalline Solids”, Advanced Drug Delivery Reviews, 48 (2001), pp. 3-26.
Brittain et al., “Polymorphism in Pharmaceutical Solids, NY” Marcel Dekker, Inc., 1999, pp. 1-2.

Affiliated with

Also associated with

Rating

Substituted thiazolidinedione derivative, process for its... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted thiazolidinedione derivative, process for its..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted thiazolidinedione derivative, process for its... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2800817